by Raynovich Rod | Sep 18, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools
Update-1 A bit of a sell-off on end of week option expirations and cancellation of China visit to farm Bureau in MT. NAZ down 0.8%, S&P down 0.5%. Less reaction to China news now? Can biotech rally as contrian play to tech and industrials? tape in biotech was...
by Raynovich Rod | Aug 28, 2019 | Biopharmaceuticals
Update-1 Aug 31 Saturday-Biotech Stocks on the Road to Nowhere? IBB flat for the week at $102.89, down 5 pts for the month. XBI flat for the week at $80.37 down 7 pts for the month. Alexion (ALXN) down 10.17% to $100.76 on patent challenge from Amgen (AMGN) on...
by Raynovich Rod | Jul 28, 2019 | Biopharmaceuticals
8/5… Risk OFF with Trade War and a Currency War XBI down 3.33% to $81.22, IBB down 2.65% to $102.29. WE will update later this week. Tuesday 8/6 we will attend the AACC Clinical EXPO in Anaheim CA. ======== Update-2..8/1 1:30p VRTX sparks biopharma stocks up 6%...
by Raynovich Rod | Jun 30, 2019 | Biopharmaceuticals
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin...
by Raynovich Rod | May 28, 2019 | Biopharmaceuticals, Macro
Update-2 5/31 2:15 p EDT. Impossible to invest with current Tariff Headwinds-XBI down 1.24% to $79.83. NASDAQ down 1.33%. ========= Update-1 5/29… Better Tape Today Off Lows Despite 1.1% Drop in IBB and 0.93% in XBI One of our top picks from JPM was Amarin...
by Raynovich Rod | May 12, 2019 | Biopharmaceuticals
Update-3 12:30 P EDT ASCO Rally seems too be kicking in.Green Screen! Update-2 5/15 10;45a EDT Gene therapy and mid-cap biopharma getting traction this am.XBI up 0.7% to $82.44. Update-1 5/14 3:30P EDT,Mid and small cap biotechs rally with NASDAQ, XBI up over 2%. Per...
by Raynovich Rod | May 5, 2019 | Biopharmaceuticals
Traders -look for a turnaround in small cap biopharma and medtech today. NAZ at 7890. 5/10 1:30p EDT….Well we know now that even biotech stocks are not immune to tariffs. Risk off. Major ETFS IBB at 104.5 and XBI near 84 are at intermediate support and off lows...
by Raynovich Rod | Mar 22, 2019 | Biopharmaceuticals
Update -2 March 24…Concerns about global growth, an inverted TSY yield curve and the German 10 year bond yield dropping below 10% triggered a major sell-off on Friday.The Russell 2000 dropped 3.62%. and the XBI dropped 4.62%. For the week ending 3/22: the XBI...
by Raynovich Rod | Aug 31, 2018 | Biopharmaceuticals
9/4/18 Biotech Weakness -Profit Taking or Caution for September Swoon? 1 PM EDT FBT down 1.38%, IBB down 1.55%, XBI down 0.73% Biotech stocks were extremely weak as of mid-day trading. Large caps were unusually weak given that they should be less volatile: CELG down...
by Raynovich Rod | Aug 28, 2018 | Biopharmaceuticals
8/30/18 Weak Rally to another Round of Highs Curbed by more Tough Tariff Threats This week’s rally and uber bullish sentiment was slowed by Tough Talk about $200B in new tariffs next week. Other news from Trump on Google, Facebook and Amazon threatening...